Triclosan targets lipid synthesis. [Nature. 1998] - PubMed

loading

Molecular basis of triclosan activity. [Nature. 1999]
Molecular basis of triclosan activity.
Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB. Nature. 1999 Apr 1; 398(6726):383-4.
A triclosan-resistant bacterial enzyme. [Nature. 2000]
A triclosan-resistant bacterial enzyme.
Heath RJ, Rock CO. Nature. 2000 Jul 13; 406(6792):145-6.
Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. [Biochemistry. 1999]
Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E, Nichols WW, Colls JG, Minshull CA, Jude DA, et al. Biochemistry. 1999 Sep 21; 38(38):12514-25.
Review Triclosan: a widely used biocide and its link to antibiotics. [FEMS Microbiol Lett. 2001]
Review Triclosan: a widely used biocide and its link to antibiotics.
Schweizer HP. FEMS Microbiol Lett. 2001 Aug 7; 202(1):1-7.
Review Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. [Surg Infect (Larchmt). 2002]
Review Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan.
Gilbert P, McBain AJ. Surg Infect (Larchmt). 2002; 3 Suppl 1:S55-63.

A novel selection marker for efficient DNA cloning and recombineering in E. coli. [PLoS One. 2013]
A novel selection marker for efficient DNA cloning and recombineering in E. coli.
Jang CW, Magnuson T. PLoS One. 2013; 8(2):e57075. Epub 2013 Feb 20.
Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents. [ChemMedChem. 2013]
Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.
Schrader FC, Glinca S, Sattler JM, Dahse HM, Afanador GA, Prigge ST, Lanzer M, Mueller AK, Klebe G, Schlitzer M. ChemMedChem. 2013 Mar; 8(3):442-61. Epub 2013 Jan 22.
Towards a new tuberculosis drug: pyridomycin - nature's isoniazid. [EMBO Mol Med. 2012]
Towards a new tuberculosis drug: pyridomycin - nature's isoniazid.
Hartkoorn RC, Sala C, Neres J, Pojer F, Magnet S, Mukherjee R, Uplekar S, Boy-Röttger S, Altmann KH, Cole ST. EMBO Mol Med. 2012 Oct; 4(10):1032-42. Epub 2012 Sep 17.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Protein Clusters
Clusters of related proteins from the Protein Clusters database that cite the current articles. Sources of references in Protein Clusters include the associated Gene and Conserved Domain records as well as NCBI added citations.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
Protein
Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Triclosan targets lipid synthesis.
Triclosan targets lipid synthesis.
Nature. 1998 Aug 6 ;394(6693):531-2.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed